|
Suppliers for CAS
379231-04-6
|
Properties | | CAS |
379231-04-6 | | Formula |
C27H32ClN5O5 |
|
|
13 Registered suppliers
Amadis Chemical Company Limited
P.R.China
More details are to be found here
Dayang Chem (Hangzhou) Co.,Ltd.
P.R.China
More details are to be found here
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd)
P.R.China
More details are to be found here
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C27H32ClN5O5 Molecular Weight: 542.03
More details are to be found here
Aea.ltd
P.R.China
Molecular Formula: C27H32ClN5O5 Molecular Weight: 542.03
More details are to be found here
Molecular Formula: C27H32ClN5O5 Molecular Weight: 542.03
More details are to be found here
Hangzhou Zhongqi Chem Co., Ltd
P.R.China
Molecular Formula: C27H32ClN5O5 Molecular Weight: 542.03
More details are to be found here
Hangzhou Lingrui Chemical Co., Ltd.
P.R.China
Molecular Formula: C27H32ClN5O5 Molecular Weight: 542.03
More details are to be found here
Skyrun Industrial Co., Ltd.
P.R.China
Molecular Formula: C27H32ClN5O5 Molecular Weight: 542.03
More details are to be found here
BOC Sciences
USA
Description : Saracatinib, also known as AZD0530, is an orally available dual-specific inhibitor of Src and Abl with anti-invasive and anti-tumor activities. Src and Abl are protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. Saracatinib binds to and inhibits these tyrosine kinases and their effects on cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, Saracatinib inhibits Src kinase-mediated osteoclast bone resorption. - Molecular Weight :542.03
- Purity :> 98%
Molecular Formula : C27H32ClN5O5 Canonical SMILES : CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6
InChI :
InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)
InChIKey :
OUKYUETWWIPKQR-UHFFFAOYSA-N
Appearance :
white solid powder
Application :
Antineoplastic Agents
Synonyms :
AZD 0530; AZD-0530; AZD0530
More details are to be found here
Xiamen Equation Chemical Co.,Ltd
P.R.China
Description : Saracatinib, also known as AZD0530, is an orally available dual-specific inhibitor of Src and Abl with anti-invasive and anti-tumor activities. Src and Abl are protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. Saracatinib binds to and inhibits these tyrosine kinases and their effects on cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, Saracatinib inhibits Src kinase-mediated osteoclast bone resorption. - Molecular Weight :542.03
- Purity :> 98%
Molecular Formula : C27H32ClN5O5 Canonical SMILES : CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6
InChI :
InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)
InChIKey :
OUKYUETWWIPKQR-UHFFFAOYSA-N
Appearance :
white solid powder
Application :
Antineoplastic Agents
Synonyms :
AZD 0530; AZD-0530; AZD0530
More details are to be found here
Chemos GmbH & Co. KG
Germany
Description : Saracatinib, also known as AZD0530, is an orally available dual-specific inhibitor of Src and Abl with anti-invasive and anti-tumor activities. Src and Abl are protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. Saracatinib binds to and inhibits these tyrosine kinases and their effects on cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, Saracatinib inhibits Src kinase-mediated osteoclast bone resorption. - Molecular Weight :542.03
- Purity :> 98%
Molecular Formula : C27H32ClN5O5 Canonical SMILES : CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6
InChI :
InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)
InChIKey :
OUKYUETWWIPKQR-UHFFFAOYSA-N
Appearance :
white solid powder
Application :
Antineoplastic Agents
Synonyms :
AZD 0530; AZD-0530; AZD0530
More details are to be found here
BuGuCh & Partners
Germany
Description : Saracatinib, also known as AZD0530, is an orally available dual-specific inhibitor of Src and Abl with anti-invasive and anti-tumor activities. Src and Abl are protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. Saracatinib binds to and inhibits these tyrosine kinases and their effects on cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, Saracatinib inhibits Src kinase-mediated osteoclast bone resorption. - Molecular Weight :542.03
- Purity :> 98%
Molecular Formula : C27H32ClN5O5 Canonical SMILES : CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6
InChI :
InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)
InChIKey :
OUKYUETWWIPKQR-UHFFFAOYSA-N
Appearance :
white solid powder
Application :
Antineoplastic Agents
Synonyms :
AZD 0530; AZD-0530; AZD0530
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : Saracatinib, also known as AZD0530, is an orally available dual-specific inhibitor of Src and Abl with anti-invasive and anti-tumor activities. Src and Abl are protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. Saracatinib binds to and inhibits these tyrosine kinases and their effects on cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, Saracatinib inhibits Src kinase-mediated osteoclast bone resorption. - Molecular Weight :542.03
- Purity :> 98%
Molecular Formula : C27H32ClN5O5 Canonical SMILES : CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6
InChI :
InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)
InChIKey :
OUKYUETWWIPKQR-UHFFFAOYSA-N
Appearance :
white solid powder
Application :
Antineoplastic Agents
Synonyms :
AZD 0530; AZD-0530; AZD0530
More details are to be found here
|
_Co_Ltd_1_575.jpg){kind=logo}
details
details